台洲游戏十三水下载 is an atypical antipsychotic developed by Dainippon Sumitomo Pharm and marketed by Sunovion in the U.S. It has been an FDA approved treatment for schizophrenia since 2010 and for treating depressive episodes in adults with bipolar I disorder since 2013. It can be used alone or in combination with mood stabilizers such as lithium or valproate. We have several analysis route of lurasidone. Lurasidone has many Intermediates, such as cas 367514-87-2, cas 46022-05-3, cas 65376-05-8, cas 186204-35-3, cas 186204-37-53, cas 2746-19-2, cas 14805-29-9, and cas 87691-87-0. Usually Lurasidone Intermediate cas 14805-29-9 and cas 186204-35-3 are in match. We supply these two intermediates in tons. Lurasidone and its intermediates are Jinan Jianfeng Chemical top products. We have mature technology and production. Waiting your inquiry any time.